Hi Osi, You take the wording of "extended" to mean more uses of midkine in their development program. I took it to mean as extended the time that they would need to have access to the license. If it is extended uses , then it could possibly be celera as i noticed they have lodged for a second US patent in September 2011 in relation to their cancer diagnostics work. First being lodged earlier 2011.
shareholder movement update, page-23
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
